These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30048963)

  • 1. Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.
    Pan X; Han Y; Zou T; Zhu G; Xu K; Zheng J; Zheng M; Cheng X
    Dig Dis; 2018; 36(6):427-436. PubMed ID: 30048963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.
    Yu R; Shi Q; Liu L; Chen L
    BMC Gastroenterol; 2018 Apr; 18(1):51. PubMed ID: 29673321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Cai C; Song X; Chen Y; Chen X; Yu C
    Hepatol Int; 2020 Jan; 14(1):115-126. PubMed ID: 31290072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis.
    Harring M; Golabi P; Paik JM; Shah D; Racila A; Cable R; Srishord M; Younossi ZM
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2876-2888.e5. PubMed ID: 36848980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Han E; Lee YH; Kim YD; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Nam HS; Heo JH; Kim SU
    Am J Gastroenterol; 2020 Apr; 115(4):584-595. PubMed ID: 32141917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.
    Chun HS; Lee M; Lee HA; Oh SY; Baek HJ; Moon JW; Kim YJ; Lee J; Kim H; Kim HY; Yoo K; Kim TH; Kim SU
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):358-369.e12. PubMed ID: 34998993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis.
    Song W; Yoo SH; Jang J; Baik SJ; Lee BK; Lee HW; Park JS
    Gut Liver; 2023 Jan; 17(1):130-138. PubMed ID: 36472070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression.
    Hsieh YC; Joo SK; Koo BK; Lin HC; Lee DH; Chang MS; Park JH; So YH; Kim W;
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):388-397.e10. PubMed ID: 35101634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of sarcopenia with liver fibrosis and steatohepatitis in non-alcoholic fatty liver disease: protocol for a systematic review and meta-analysis.
    Wang Z; Li S; Wang K; Zhang M; Wu J; Liu D; Liang K
    BMJ Open; 2023 Feb; 13(2):e066181. PubMed ID: 36737085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Bhanji RA; Narayanan P; Allen AM; Malhi H; Watt KD
    Hepatology; 2017 Dec; 66(6):2055-2065. PubMed ID: 28777879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
    Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
    Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study.
    Lee HJ; Lee DC; Kim CO
    Front Endocrinol (Lausanne); 2021; 12():599339. PubMed ID: 33868162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advances in the relationship between nonalcoholic fatty fiver disease and sarcopenia].
    Yu R; Shi QW; Wang CF; Chen LD; Zhang LF
    Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):725-727. PubMed ID: 31594102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease.
    Chun HS; Lee M; Lee HA; Lee S; Kim S; Jung YJ; Lee C; Kim H; Lee HA; Kim HY; Yoo K; Kim TH; Ahn SH; Kim SU
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2298-2307.e18. PubMed ID: 36462755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?
    De Fré CH; De Fré MA; Kwanten WJ; Op de Beeck BJ; Van Gaal LF; Francque SM
    Obes Rev; 2019 Feb; 20(2):353-363. PubMed ID: 30474288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.